Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19)
NCT04456556 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2020-07-02
Summary
To report on cases presented with combined endophthalmitis and orbital cellulitis as a first presentation of covid-19 infection.
Conditions
- Endophthalmitis and Orbital Cellulitis
Sponsors & Collaborators
-
Minia University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-27
- Primary Completion
- 2020-06-20
- Completion
- 2020-06-30
Countries
- Egypt
Study Locations
More Related Trials
-
CsA vs MMC for Preventing Pterygium Recurrence
NCT06944132 ·Status: COMPLETED ·Phase: NA
-
Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia
NCT02199327 ·Status: COMPLETED ·Phase: PHASE4
-
Endogenous Endophthalmitis in the Inpatient Setting
NCT01323868 ·Status: COMPLETED
-
Clinical Feature and Treatment of Microsporidial Keratoconjunctivitis
NCT03555409 ·Status: UNKNOWN
-
Investigating Epstein-Barr Virus Associated Conjunctivitis
NCT06689397 ·Status: ENROLLING_BY_INVITATION
-
Dry Eye Under China's Dynamic COVID-zero Strategy
NCT05476068 ·Status: COMPLETED
-
The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study
NCT05655689 ·Status: COMPLETED
-
Detecting SARS-CoV-2 in Tears
NCT04526769 ·Status: COMPLETED
-
Evaluation of Lacrimal Punctal Changes by Anterior Segment Optical Coherence Tomography AS-OCT After Topical Combined Antibiotics and Steroids Treatment in Cases of Inflammatory Punctual Stenosis
NCT05028907 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)
NCT00894530 ·Status: COMPLETED ·Phase: PHASE2
-
Prevalence of Different Etiologies of Ocular Dryness in Patients Previously Diagnosed With Dry Eye Disease in A Sample of Egyptian Patients
NCT05598437 ·Status: UNKNOWN
-
Medication Compliance in the Paediatric Uveitis Population Reported by the Patients and Parents
NCT04148365 ·Status: COMPLETED
-
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients
NCT01697969 ·Status: COMPLETED ·Phase: PHASE4
-
Intense Regulated Pulse Light Therapy in Dry Eye Disease
NCT05553561 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period
NCT00892970 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation and Treatment of Patients With Corneal and External Diseases
NCT00008541 ·Status: COMPLETED
-
Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis
NCT05689996 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia
NCT00383396 ·Status: COMPLETED ·Phase: PHASE4
-
Low Dose Doxycycline in the Treatment of Corneal Burn
NCT01886560 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects
NCT03660475 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Manuka Eye Drops on Tear Film Properties
NCT03622619 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis
NCT00656539 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis
NCT00629941 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Amniotic Membrane Extract Eye Drops as an Adjunctive Therapy in Resistant Corneal Ulcers
NCT06909149 ·Status: COMPLETED ·Phase: NA
-
The Ocular Microbiome in Patients With Dry Eye Disease
NCT04656197 ·Status: COMPLETED